【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2.1. Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.3. Pricing Analysis
3.3.1. Pricing Analysis, By Region, 2018 & 2025
3.4. Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.8.1. Case Study 01
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.2. Restraints
3.9.2.1. High cost of treatment
3.9.2.2. Stringent approval process
3.9.3. Opportunities
3.9.3.1. Lucrative opportunities in emerging economies
CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.2. Market size and forecast
4.3. Vital organs support systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Artificial Heart
4.3.2.1.1. Market size and forecast
4.3.2.2. Artificial Kidney
4.3.2.2.1. Market size and forecast
4.3.2.3. Artificial Pancreas
4.3.2.3.1. Market size and forecast
4.3.2.4. Artificial Urinary Bladder
4.3.2.4.1. Market size and forecast
4.3.2.5. Artificial Lungs
4.3.2.5.1. Market size and forecast
4.3.2.6. Artificial Liver
4.3.2.6.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country
4.4. Medical Bionics
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Bionic Eye
4.4.2.1.1. Market size and forecast
4.4.2.2. Ear Bionics
4.4.2.2.1. Market size and forecast, by type
4.4.2.2.1.1.1. Cochlear Implants
4.4.2.2.1.1.1.1 Market size and forecast
4.4.2.2.1.1.2. Bone Anchored Hearing Systems
4.4.2.2.1.1.2.1. Market size and forecast
4.4.2.2.1.1.3. Auditory Brainstem Implants
4.4.2.2.1.1.3.1 Market size and forecast
4.4.2.3. Orthopedic Bionics
4.4.2.3.1. Market size and forecast, by type
4.4.2.3.1.1.1. Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.4.1. Bionic Knee
4.4.2.3.1.1.4.1.1. Market size and forecast
4.4.2.3.1.1.4.2. Bionic Feet
4.4.2.3.1.1.4.2.1. Market size and forecast
4.4.2.3.1.1.5. Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.1.1. Market size and forecast
4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.2.1. Market size and forecast
4.4.2.4. Cardiac Bionics
4.4.2.4.1. Market size and forecast, by type
4.4.2.4.1.1.1. Pacemaker
4.4.2.4.1.1.1.1 Market size and forecast, by type
4.4.2.4.1.1.2. Implantable Pacemaker
4.4.2.4.1.1.2.1. Market size and forecast
4.4.2.4.1.1.3. External pacemaker
4.4.2.4.1.1.3.1 Market size and forecast
4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)
4.4.2.4.1.1.4. Market size and forecast, by type
4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)
4.4.2.4.1.1.4.1.1. Market size and forecast
4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)
4.4.2.4.1.1.4.2.1. Market size and forecast
4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)
4.4.2.4.1.1.4.3.1. Market size and forecast
4.4.2.4.1.1.5. Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6.1. Mechanical Heart Valves
4.4.2.4.1.1.6.1.1. Market size and forecast
4.4.2.4.1.1.6.2. Tissue Heart Valves
4.4.2.4.1.1.6.2.1. Market size and forecast
4.4.2.5. Neural Bionics
4.4.2.5.1. Market size and forecast, by type
4.4.2.5.1.1. Internal Neurostimulators
4.4.2.5.1.1.1. Market size and forecast, by type
4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)
4.4.2.5.1.1.1.1.1. Market size and forecast
4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)
4.4.2.5.1.1.1.2.1. Market size and forecast
4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)
4.4.2.5.1.1.1.3.1. Market size and forecast
4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)
4.4.2.5.1.1.1.4.1. Market size and forecast
4.4.2.5.1.1.1.5. Other Neurostimulators
4.4.2.5.1.1.1.5.1. Market size and forecast
4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.4.2.5.1.2.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country
CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
5.1. Overview
5.2. Market size and forecast
5.3. Hospitals
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Ambulatory surgical centers (ASCs)
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America vital organs support systems and medical bionics market, by country
6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3. Canada vital organs support systems and medical bionics market, by product type
6.2.2.4. Canada vital organs support systems and medical bionics market, by end user
6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user
6.2.3. North America vital organs support systems and medical bionics market, by product type
6.2.5. North America vital organs support systems and medical bionics market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe vital organs support systems and medical bionics market, by country
6.3.2.1. Germany vital organs support systems and medical bionics market, by product type
6.3.2.3. Germany vital organs support systems and medical bionics market, by end user
6.3.2.4. France vital organs support systems and medical bionics market, by product type
6.3.2.6. France vital organs support systems and medical bionics market, by end user
6.3.2.7. Spain vital organs support systems and medical bionics market, by product type
6.3.2.8. Spain vital organs support systems and medical bionics market, by end user
6.3.2.9. Italy vital organs support systems and medical bionics market, by product type
6.3.2.11. Italy vital organs support systems and medical bionics market, by end user
6.3.2.12. UK vital organs support systems and medical bionics market, by product type
6.3.2.13. UK vital organs support systems and medical bionics market, by end user
6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user
6.3.3. Europe vital organs support systems and medical bionics market, by product type
6.3.5. Europe vital organs support systems and medical bionics market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country
6.4.2.1. Australia vital organs support systems and medical bionics market, by product type
6.4.2.2. Australia vital organs support systems and medical bionics market, by end user
6.4.2.3. Japan vital organs support systems and medical bionics market, by product type
6.4.2.4. Japan vital organs support systems and medical bionics market, by end user
6.4.2.5. India vital organs support systems and medical bionics market, by product type
6.4.2.6. India vital organs support systems and medical bionics market, by end user
6.4.2.7. China vital organs support systems and medical bionics market, by product type
6.4.2.8. China vital organs support systems and medical bionics market, by end user
6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user
6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA vital organs support systems and medical bionics market, by country
6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user
6.5.3. LAMEA vital organs support systems and medical bionics market, by product type
6.5.5. LAMEA vital organs support systems and medical bionics market, by end user
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.4. Top winning strategies
7.4.1. Top Winning Strategies, By Year, 2015-2019*
7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)
7.4.3. Top Winning Strategies, By Company, 2015-2019*
7.5. Product Mapping of Top 12 Player
CHAPTER 8: COMPANY PROFILES:
8.1. Abiomed, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Abbott Laboratories (St. Jude Medical)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Baxter International Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Cochlear Ltd.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Edwards Lifesciences Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Jarvik Heart, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. Medtronic Plc. (Covidien Ltd.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Össur Americas, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. Second Sight Medical Products, Inc.
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Product portfolio
8.11.4. Key strategic moves and developments
8.12. SynCardia Systems LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Product portfolio
【レポート販売概要】
■ タイトル：重要臓器支援システム・メディカルバイオニクスの世界市場：製品別（重要臓器支援システム、メディカルバイオニクス）、エンドユーザー別（病院、外来手術センター、その他）■ 英文：Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025
■ 発行日：2019年5月31日
■ 調査会社：Allied Market Research
■ 商品コード：AMR9AG039
■ 調査対象地域：グローバル
- 消火泡の世界市場予測・分析2020-2024Global Firefighting Foam Market: About this market Technavio’s firefighting foam market analysis considers sales from aqueous film-forming foam, alcohol-resistant aqueous film-forming foam, protein foam, synthetic detergent foam, and other forms. Our study also finds the sales of firefighting foam in APAC, Europe, MEA, North America, and South America. In 2019, the aqueous film-forming foam segmen …
- コンテンツデリバリネットワーク（CDN）の世界市場予測（～2021年）MarketsandMarkets forecasts the Content Delivery Network (CDN) market size to grow from USD 6.05 Billion in 2016 to USD 23.22 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 30.9%. Major factors contributing to the growth of the Content Delivery Network market are expanding video content, increasing use of connected and smart devices, and proliferation of rich media over soc …
- Iclusig (Chronic Myeloid Leukemia)：市場予測と分析（～2022）Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
- Lialda(潰瘍性大腸炎)：市場分析と予測（～2022）Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting …
- サスティナブル・ツーリズムの世界市場2019-2023About this market The huge shift from traditional traveling to authentic and local travelling experiences with the changing tourist preferences has been identified as one of the critical reasons that will drive the sustainable tourism market. Tourists are undertaking adventure trips in public transport instead of taxis, purchasing local products instead of souvenirs, and dining at restaurants that …
- アルファ-マンノシドーシス（Alpha-Mannosidosis）：グローバル臨床試験レビュー（2014年上半期）Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Alpha-Mannosidosis Global Clinical Trials Review, H1, 2014" provides data on the Alpha-Mannosidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha-Mannosidosis. It includes an overview of the trial numbers and their recruitme …
- ラグジュアリーセグメント用自動運転車の世界市場予測（～2030年）“Increasing demand for luxury vehicles is set to drive the autonomous vehicle market for luxury segment”The global autonomous vehicle market for luxury segment is projected to be 27,906 units in 2025 and is projected to grow to 126,774 units by 2030, at a CAGR of 35.35%. Increasing accident fatalities coupled with rising concern for vehicle safety and security have accentuated the need for the dev …
- POSプリンターの世界市場2019-2023About this market The growth of the global POS printer market is driven by the increased adoption of mPOS printers. These printers offer the advantage of portability along with a compact design and low cost. The market is witnessing significant growth owing to the availability of cloud-based and wireless mPOS printers. mPOS printers are increasingly being deployed in restaurants, food trucks, and …
- 世界のOils and Fats市場におけるニュース・イベント動向（2014年2月）Synopsis The report provides a review of the latest news and key events in the global oils and fats market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global oils and fats market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in t …
- グローバル画像診断装置（医療機器）メーカー分析（技術能力、戦略、課題）：ShimadzuThe strategic assessment of Shimadzu, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in …
- 製造業におけるスペアパーツ用静脈物流の世界市場2018-2022About Reverse Logistics of Spare Parts for Manufacturing Industry Transportation of faulty spare parts from the customers to the original equipment manufacturer (OEM) and to the manufacturing industries is the reverse logistics operations of spare parts. Various operations performed in the reverse logistics operations are the collection of faulty spare parts, transportation, warehousing, and the r …
- 世界におけるカメラの最新技術市場：3Dデプスセンシング、赤外線・熱技術、4K解像度及びULTRA HDディスプレイ技術、CMOSイメージセンサ技術ACT is a market where recent advanced technologies are used in cameras for image capturing, depth sensing, security concerns, and image displays. The advancements in cameras have been driven by the continuous technological evolution in the present era. These technologies are widely used in several applications, which include consumer electronics, media and entertainment, industrial, robotics and g …
- 世界の動物医療市場動向：動物用ワクチン、医薬品The report titled “Global Animal Health Market Outlook to 2018 – Increasing Meat Consumption to Spur Demand for Animal Health Products” provides a detailed overview of animal health market in the world and covers various aspects such as market size of global animal health industry. Additionally the report includes segmentation on the basis of products (Pharmaceuticals, Vaccines and Animal Feed Add …
- 世界のプラスチック添加物市場動向（2014-2018）About Plastic Additives Plastic is an integral part of the modern lifestyle. The majority of plastic products are made with the help of plastic additives, which makes the end-products safer, cleaner, tougher, and colorful. Plastic additives are chemical substances that are added to a polymeric compound to process, modify or give it specific properties, which makes the end-products more useful. Pla …
- 表面殺菌剤の世界市場：次亜塩素酸塩、四級アンモニウム塩化合物、過酸化水素、グルコン酸クロルヘキシジン、過酢酸、フェノール、アルコールThe global surface disinfectants market is expected to reach USD 542.55 million by 2020 from USD 312.17 million in 2015, growing at a CAGR of 11.69% between 2015 and 2020. The product segments included in this report are hypochlorite, quaternary ammonium compounds, hydrogen peroxide, chlorhexidine gluconate, peracetic acid, chlorine dioxide, phenolic compounds, alcohols, iodine compounds and aldeh …
